Loading company…
Peptron develops peptide therapeutics, sustained-release drug delivery systems, and peptide synthesis services.
Founded in 1997 and based in South Korea, Peptron develops peptide-based medicines and sustained-release drug delivery systems, including its SmartDepot™ technology. It also provides peptide synthesis services to pharmaceutical companies and research institutions. The company has completed 9 funding deals; its most recent listed PIPE round was on July 22, 2015, raising KRW 37,999.893 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in